收费全文 | 5785篇 |
免费 | 426篇 |
国内免费 | 22篇 |
耳鼻咽喉 | 184篇 |
儿科学 | 176篇 |
妇产科学 | 158篇 |
基础医学 | 748篇 |
口腔科学 | 159篇 |
临床医学 | 466篇 |
内科学 | 1307篇 |
皮肤病学 | 115篇 |
神经病学 | 283篇 |
特种医学 | 196篇 |
外国民族医学 | 1篇 |
外科学 | 844篇 |
综合类 | 141篇 |
一般理论 | 13篇 |
预防医学 | 338篇 |
眼科学 | 100篇 |
药学 | 528篇 |
1篇 | |
中国医学 | 39篇 |
肿瘤学 | 436篇 |
2023年 | 63篇 |
2022年 | 206篇 |
2021年 | 266篇 |
2020年 | 152篇 |
2019年 | 216篇 |
2018年 | 230篇 |
2017年 | 160篇 |
2016年 | 179篇 |
2015年 | 202篇 |
2014年 | 271篇 |
2013年 | 323篇 |
2012年 | 454篇 |
2011年 | 460篇 |
2010年 | 246篇 |
2009年 | 164篇 |
2008年 | 285篇 |
2007年 | 263篇 |
2006年 | 266篇 |
2005年 | 219篇 |
2004年 | 204篇 |
2003年 | 219篇 |
2002年 | 177篇 |
2001年 | 117篇 |
2000年 | 112篇 |
1999年 | 93篇 |
1998年 | 40篇 |
1997年 | 24篇 |
1996年 | 24篇 |
1995年 | 25篇 |
1994年 | 27篇 |
1993年 | 23篇 |
1992年 | 43篇 |
1991年 | 38篇 |
1990年 | 50篇 |
1989年 | 32篇 |
1988年 | 30篇 |
1987年 | 23篇 |
1986年 | 27篇 |
1985年 | 28篇 |
1984年 | 21篇 |
1983年 | 24篇 |
1982年 | 22篇 |
1979年 | 16篇 |
1978年 | 20篇 |
1977年 | 16篇 |
1976年 | 19篇 |
1975年 | 10篇 |
1974年 | 14篇 |
1973年 | 15篇 |
1972年 | 10篇 |
Patients and methods — We included patients operated on because of cuff-tear arthropathy and reported to the Danish Shoulder Arthroplasty Registry (DSR) from January 1, 2006 to December 31, 2013. 117 RHA cases were matched by age and sex with 233 RSA controls. 34 of the RHAs were conventional and 67 were RHAs with extended articular surface. The Western Ontario Osteoarthritis of the Shoulder (WOOS) Index at 1 year was used as primary outcome. The score was converted to a percentage of a maximum score. Revision, defined as removal or exchange of any component or the addition of a glenoid component, was used as secondary outcome.
Results — Median WOOS was 49 (30–81) for RHA and 77 (50–92) for RSA (p < 0.001). For patients younger than 65 years, median WOOS was 58 (44–80) after RHA, similar to the 54 after RSA (37–85). For patients older than 65 years, median WOOS was 48 (28–82) after RHA and 79 (55–92) after RSA (p < 0.001).
Interpretation — In all patients RSA had a clinically and statistically better patient-reported outcome than RHA. However, in patients younger than 65 years the functional outcome was similar and poor for either arthroplasty type. The optimal treatment of CTA in young patients remains a challenge. 相似文献
Areas covered: This review examines ROR-1 structure and function, immunotherapeutic strategies including specific chimeric antigen receptor (CARs) T cells and miRNAs and other targeted approaches such as the use of tyrosine kinase inhibitors.
Expert opinion: Chimeric antibodies, CARs T cells, bi-specific T cell engagers (BiTEs), miRNAs and TKIs are used to target the ROR-1 marker on cancer cell lines. By selecting the most favorable therapeutic approaches regarding ROR-1 in vivo, anti-ROR-1 antibodies or CAR T cells can be also used for diagnosis of ROR-1+ cancer cells in new technologies such as biosensors. Moreover, ROR-1 targeted combination therapy with other cancer biomarkers could be considered a novel therapeutic strategy for cancer treatment. 相似文献
Background
As a recently discovered adipokine, nesfatin-1 is conducive to insulin sensitivity, lipid profile, energy balance, and probably obesity.Objective
The aim of the present study was to investigate the effect of upper-body resistance exercise training (RET) on nesfatin-1 levels, insulin resistance, lipid profile, and body composition in obese paraplegic men.Methods
Twenty obese paraplegic men were randomly assigned into control and upper-body RET groups. Upper-body RET was performed for 8 weeks, 3 sessions per week at an intensity corresponding to 60–80% maximum amount of force that can be generated in one maximal contraction in 5 stations (bench press, seated rows, sitting lat pulldown, arm extension, and arm curls). Body fat percentage was determined according to 4-sites skinfold protocol of Durnin and Womersley and Siri equation. Obesity for spinal cord injury patients in the current study was set at BMI >22?kg/m2. Data were statistically analyzed by paired and independent t-test (P?<?0.05).Results
We found significant improvements in serum levels of nesfatin-1 (21.13%), insulin sensitivity (8.95%), and high-density lipoprotein (10.87%). Other lipid profile markers, i.e. low-density lipoprotein (4.32%), cholesterol (8.20%), and triglyceride (15.10%) reduced significantly after upper-body RET. Moreover, upper-body RET led to a significant reduction in body mass index (2.36%), body fat percentage (2.79%), and waist-to-hip ratio (2.40%).Conclusion
Upper-body RET improved insulin sensitivity, lipid profile, and body composition in paraplegic men. Serum nefastin-1 may be a potential marker of success in weight management in this population. 相似文献![点击此处可从《The clinical respiratory journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)